Orchid Pharma Limited

Orchid Pharma Limited (ORCHPHARMA) is a small-cap Healthcare company valued at ₹5,457 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Orchid Pharma Limited last traded at ₹925, down 2.14% on the day.

Recent developments

On 2026-06-30, the company reported a net profit of ₹3 crore for the latest quarter, reversing a net loss of ₹6 crore in the same quarter a year earlier. Promoter holding remained at 69.84%, while domestic institutional holding increased by 0.50 points.

Financial performance

The company's revenue grew 33.7% annually, but net profit fell 90.0% year-on-year. In the latest quarter, revenue rose 15.6% compared to the same quarter a year earlier, while net profit swung from a loss of ₹6 crore to a profit of ₹3 crore.

Valuation multiples

The stock trades at 42.1 times earnings, a premium to the Healthcare median of 32.0, 4.69 times book value.

Things to watch

The company's net profit margin narrowed 10.0 percentage points to 0.8%, and return on equity is 0.0%. The stock is 13.4% below its 52-week high, and the company has not paid dividends despite reporting profits.

Where it stands

The company's revenue has grown steadily, but net profit has declined sharply. The latest quarter showed a turnaround from a loss to a profit, but the net profit margin remains very low. The stock is trading below its 52-week high, and the company has not distributed any dividends.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.